Arbeitsgemeinschaft Medikamentöse Tumortherapie

Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT) is a prominent Austrian academic research organization (ARO) specializing in the coordination and management of clinical trials in oncology. Established as a non-profit entity, AGMT facilitates independent clinical research by collaborating with a vast network of hospitals, academic institutions, and pharmaceutical partners. The organization focuses on improving cancer treatment outcomes through the investigation of novel therapeutic strategies, including immunotherapies and targeted molecular agents. AGMT's expertise spans the entire clinical trial lifecycle, from protocol design and regulatory submission to data monitoring and statistical analysis. By conducting high-quality, investigator-initiated trials, AGMT contributes essential data to the global medical community, particularly in the areas of lung, breast, and gastrointestinal cancers.